Balter Invenomic Fund Quote

BIVRX Fund  USD 17.09  0.10  0.58%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 22

 
High
 
Low
Low
Balter Invenomic is trading at 17.09 as of the 4th of December 2024; that is 0.58 percent down since the beginning of the trading day. The fund's open price was 17.19. Balter Invenomic has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Balter Invenomic Fund are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 15th of December 2022 and ending today, the 4th of December 2024. Click here to learn more.
The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio , while allowing the size of the short portfolio to fluctuate based on the market opportunity. More on Balter Invenomic Fund

Moving together with Balter Mutual Fund

  0.9BIVIX Balter InvenomicPairCorr

Moving against Balter Mutual Fund

  0.51FPPJX Mfs Prudent InvestorPairCorr
  0.49AMHYX Invesco High YieldPairCorr
  0.48ASLAX Ab Select LongshortPairCorr
  0.43NLSCX Neuberger Berman LongPairCorr
  0.42NLSAX Neuberger Berman LongPairCorr
  0.42NLSIX Neuberger Berman LongPairCorr

Balter Mutual Fund Highlights

Fund ConcentrationInvenomic Funds, Large Funds, Long-Short Equity Funds, Long-Short Equity, Invenomic (View all Sectors)
Update Date30th of September 2024
Expense Ratio Date1st of March 2023
Fiscal Year EndOctober
Balter Invenomic Fund [BIVRX] is traded in USA and was established 4th of December 2024. Balter Invenomic is listed under Invenomic category by Fama And French industry classification. The fund is listed under Long-Short Equity category and is part of Invenomic family. This fund currently has accumulated 1.4 B in assets under management (AUM) with no minimum investment requirementsBalter Invenomic is currently producing year-to-date (YTD) return of 1.81% with the current yeild of 0.02%, while the total return for the last 3 years was 19.47%.
Check Balter Invenomic Probability Of Bankruptcy

Instrument Allocation

Sector Allocation

Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Balter Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Balter Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Balter Invenomic Fund Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.

Top Balter Invenomic Fund Mutual Fund Constituents

AVDAmerican VanguardStockMaterials
RJFRaymond James FinancialStockFinancials
SKTTanger Factory OutletStockReal Estate
FDXFedExStockIndustrials
CMCSAComcast CorpStockCommunication Services
HSIIHeidrick Struggles InternationalStockIndustrials
MCKMcKessonStockHealth Care
GPKGraphic Packaging HoldingStockMaterials
More Details

Balter Invenomic Risk Profiles

Balter Invenomic Against Markets

Other Information on Investing in Balter Mutual Fund

Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals